These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2104964)

  • 1. Failure of prostacyclin to improve peripheral arterial disease in dialysis patients.
    Ruggenenti P; Viganò G; Mecca G; Cassina G; Remuzzi G
    Nephron; 1990; 54(1):93-4. PubMed ID: 2104964
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prostacyclin therapy of peripheral artery disease].
    Kusaba A
    Kokyu To Junkan; 1985 Jul; 33(7):871-6. PubMed ID: 3903902
    [No Abstract]   [Full Text] [Related]  

  • 3. A double blind placebo controlled trial of intravenous prostacyclin (PGI2) in 108 patients with ischaemic peripheral vascular disease.
    Virgolini I; Fitscha P; Linet OI; O'Grady J; Sinzinger H
    Prostaglandins; 1990 Jun; 39(6):657-64. PubMed ID: 2115186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trial of a novel prostacyclin analog, UT-15, in patients with severe intermittent claudication.
    Mohler ER; Klugherz B; Goldman R; Kimmel SE; Wade M; Sehgal CM
    Vasc Med; 2000; 5(4):231-7. PubMed ID: 11213235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostacyclin treatment of ischemic ulcers and rest pain in unreconstructible peripheral arterial occlusive disease.
    Cronenwett JL; Zelenock GB; Whitehouse WM; Lindenauer SM; Graham LM; Stanley JC
    Surgery; 1986 Aug; 100(2):369-75. PubMed ID: 3526609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [EDTA treatment of arteriosclerosis. Bias or manipulation?].
    Jørgensen SJ; Guldager B; Jelnes R
    Ugeskr Laeger; 1992 Jun; 154(23):1645-6. PubMed ID: 1632000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arteriographic findings in EDTA chelation therapy on peripheral arteriosclerosis.
    Sloth-Nielsen J; Guldager B; Mouritzen C; Lund EB; Egeblad M; Nørregaard O; Jørgensen SJ; Jelnes R
    Am J Surg; 1991 Aug; 162(2):122-5. PubMed ID: 1907432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effect of treatment with a prostacyclin analogue in severe peripheral atherosclerosis. A case report.
    Risberg B; Bergdahl S; Kjellström BT; Ortenwall P; Seeman T
    Acta Chir Scand; 1986; 152():477-8. PubMed ID: 3532656
    [No Abstract]   [Full Text] [Related]  

  • 9. Peripheral vasodilators versus pentoxifylline for the treatment of intermittent claudication.
    Aviado DM
    Ric Clin Lab; 1983; 13 Suppl 3():263-8. PubMed ID: 6143383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostanoid drug therapy for peripheral arterial occlusive disease--the European experience.
    Dormandy JA
    Vasc Med; 1996; 1(2):155-8. PubMed ID: 9546931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of prostacyclin in atherosclerotic vascular disease.
    Gryglewski RJ
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():539-42. PubMed ID: 2936165
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of nicergoline in peripheral arteriopathies of the lower limbs. Double-blind study].
    Coscia M
    Minerva Cardioangiol; 1972 Sep; 20(9):497-504. PubMed ID: 4561065
    [No Abstract]   [Full Text] [Related]  

  • 13. Reliability of treadmill testing in peripheral arterial disease: a comparison of a constant load with a graded load treadmill protocol.
    Labs KH; Nehler MR; Roessner M; Jaeger KA; Hiatt WR
    Vasc Med; 1999; 4(4):239-46. PubMed ID: 10613628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent.
    Zusman RM; Rubin RH; Cato AE; Cocchetto DM; Crow JW; Tolkoff-Rubin N
    N Engl J Med; 1981 Apr; 304(16):934-9. PubMed ID: 7010166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of ticlopidine on lower limb blood flow, ankle/brachial index and symptoms in peripheral arteriosclerosis. A double-blind study. The STIMS Group in Lund. Swedish Ticlopidine Multicenter Study.
    Fagher B
    Angiology; 1994 Sep; 45(9):777-88. PubMed ID: 8092543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of iloprost in patients with intermittent claudication.
    Creager MA; Pande RL; Hiatt WR
    Vasc Med; 2008 Feb; 13(1):5-13. PubMed ID: 18372433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled study of heparin versus epoprostenol sodium (prostacyclin) as the sole anticoagulant for chronic hemodialysis.
    Caruana RJ; Smith MC; Clyne D; Crow JW; Zinn JM; Diehl JH
    Blood Purif; 1991; 9(5-6):296-304. PubMed ID: 1819317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral arterial occlusive disease: conservative treatment of intermittent claudication.
    Kriessmann A
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S72-4. PubMed ID: 1369724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double blind trial of nialamide in intermittent claudication. Effects on blood cholesterol, fibrinolysis and 5-hydroxytryptamine.
    Tsapogas MJ; Flute PT
    Vasc Dis; 1964 Sep; 1(5):249-51. PubMed ID: 4867905
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostacyclin and heparin during haemodialysis: comparative effects.
    Camici M; Evangelisti L
    Life Support Syst; 1986; 4(3):205-9. PubMed ID: 3537544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.